English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Open

Presents the pdf analysis as premium feature

PDF Analysis

Insights

Presents the summarisation as premium feature

Summarisation

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Background  A retrospective analysis of clinical data from primary  S jogren's syndrome ( pSS ) patients with lung cancer was conducted in order to guide further clinical work.    Methods  From  J anuary 1993 to  D ecember 2010, 10  pSS  patients with lung cancer were hospitalized at the  P eking  U nion  M edical  C ollege  H ospital. One hundred and three p SS  patients were recruited as the controls. Patients' clinical data was retrospectively analyzed.    Result  The incidence rate of lung cancer in  pSS  patients was 0.477%. The duration from diagnosis of  pSS  to lung cancer in the 10 patients was 0.92∼42 years. The  pSS  patients with lung cancer were significantly older than those without lung cancer (60.8 ± 8.9 vs. 44.9 ± 12.1,  P  < 0.001). Eight of the  pSS  patients with lung cancer (80%) were female nonsmokers; five  pSS  patients with lung cancer (50%) had lung involvement, exhibiting diffuse parenchymal lung disease. Adenocarcinoma was the most common pathological type of lung cancer (90%). Tumor node metastasis staging of lung cancer included: four cases of Ib (40%), one case of  IIIb  (10%), four cases of  IV  (40%) and one case undetermined (10%).    Conclusion  The incidence rate of lung cancer in  pSS  patients was higher with respect to the normal population. Physicians should closely observe lung cancer incidence during the  pSS  follow‐up period. Adenocarcinoma was the most frequently seen lung cancer pathology in  pSS  patients. Clinical stages and individualized treatment for  pSS  patients with lung cancer should be carefully determined.

thoracic cancer

The Prevalence and clinical characteristics of primary  S jogren's syndrome patients with lung cancer: An analysis of ten cases in  C hina and literature review